Cover image for The economic dynamics of modern biotechnology
Title:
The economic dynamics of modern biotechnology
Publication Information:
Cheltenham, UK : Edward Elgar, 2004
ISBN:
9781843765196

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010059992 HD9999.B443 E26 2004 Open Access Book Book
Searching...

On Order

Summary

Summary

This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms.

This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analysing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research.

The Economic Dynamics of Modern Biotechnology will become essential reading for students, scholars and researchers of the management and economics of innovation, business strategy, industrial organization, the theory of the firm, the economics of technological change, and regional studies. It will also appeal to a wider political and business audience such as government policymakers and managers of biotechnology firms.


Author Notes

Edited by Maureen McKelvey, Professor, School of Business, Economics and Law, University of Gothenburg, Annika Rickne, Professor, Royal Institute of Technology and Jens Laage-Hellman, Associate Professor, Department of Technology Management and Economics, Chalmers University of Technology, Sweden


Table of Contents

Jens Laage-Hellman and Maureen McKelvey and Annika RickneJohan Brink and Maureen McKelvey and Keith SmithMaureen McKelvey and Annika Rickne and Jens Laage-HellmanMichel QuereJacqueline SenkerMichael M. Hopkins and Paul NightingaleFinn Valentin and Rasmus Lund JensenStefano Brusoni and Rachel Cutts and Aldo GeunaAndrew McMeekin and Mark Harvey and Sally GeeJohan Brink and Linus Dahlander and Maureen McKelveyAnnika RickneSteven Casper and Fiona MurrayCorinne Autant-Bernard and Vincent Mangematin and Nadine MassardHannah Kettler and Maureen McKelvey and Luigi Orsenigo
List of contributorsp. vii
Prefacep. ix
Part I Introduction
1 Introductionp. 3
2 Conceptualizing and measuring modern biotechnologyp. 20
Part II Setting the Scene
3 Stylized facts about innovation processes in modern biotechnologyp. 43
4 The post-genome era: rupture in the organization of the life science industry?p. 76
5 An overview of biotechnology innovation in Europe: firms, demand, government policy and researchp. 99
Part III Challenging the Existing
6 Risk management and the commercialization of human genetic testing in the UKp. 135
7 Networks and technology systems in science-driven fields: the case of European food biotechnologyp. 167
8 Future imperfect: the response of the insurance industry to the emergence of predictive genetic testingp. 207
9 Emergent bioinformatics and newly distributed innovation processesp. 235
Part IV Forming the New
10 The dynamics of regional specialization in modern biotechnology: comparing two regions in Sweden and two regions in Australia, 1977-2001p. 265
11 On the spatial dimension of firm formationp. 295
12 Examining the marketplace for ideas: how local are Europe's biotechnology clusters?p. 326
13 Creation and growth of high-tech SMEs: the role of the local environmentp. 356
Part V Conclusions
14 Reflections and ways forwardp. 395
Indexp. 407